Assessing Verbio (XTRA:VBK) Valuation After Return To Profitability And Higher Biofuel Output

Why Verbio’s latest earnings are in focus Verbio (XTRA:VBK) is back in the spotlight after its second quarter and half year results to 31 December 2025 showed quarterly profitability, higher sales, and increased bioethanol and biomethane production. Those headline figures, together with an earlier share price move ahead of the announcement, have drawn fresh attention from investors who are assessing how the company’s fuel mix and operating scale are affecting the quality of its earnings. See our latest analysis for Verbio. Verbio’s share price has been volatile around these earnings, with a 1-day share price return of 1.85% and a 90-day share price return of 46.20%. The 1-year total shareholder return of 161.49% contrasts with weaker 3 and 5 year total shareholder returns. If Verbio’s recent swing has caught your attention, it can be useful to see what else is moving in related areas, starting with 25 power grid technology and infrastructure stocks. With the shares up 46.20% in 90 days and trading at €24.24 against an estimated intrinsic value gap of around 72%, the key question now is whether Verbio is still mispriced or if the market is already pricing in future growth. Most Popular Narrative: 28.3% Overvalued Verbio’s most followed valuation narrative puts fair value at €18.90, which sits well below the latest close of €24.24 and frames the current debate around the stock. The combination of European utilization and U.S. ramp provides two distinct earnings drivers. Bullish analysts see this as helpful for sustaining the current valuation framework if execution stays on track. Read the complete narrative. Want to see what kind of revenue growth, margin lift, and future earnings power that sentence is built on? The narrative sets clear targets, tight assumptions, and a specific profit profile for Verbio. The full story is in how those inputs connect to that €18.90 fair value and what needs to happen in the business to get there. Result: Fair Value of €18.90 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you also need to watch for weaker quota prices or slower U.S. ramp up, as these could pressure EBITDA and make those €18.90 assumptions harder to support. Find out about the key risks to this Verbio narrative. Another View: Cash Flows Tell a Different Story That €18.90 fair value based on earnings expectations puts Verbio in the “overvalued” camp, yet our DCF model paints a very different picture. It indicates a future cash flow value of €86.15, and with the shares at €24.24, this suggests the stock is trading at a steep discount. So which lens do you trust more? Look into how the SWS DCF model arrives at its fair value. VBK Discounted Cash Flow as at Feb 2026 Build Your Own Verbio Narrative If you look at these numbers and come to a different conclusion, or simply prefer to test your own assumptions, you can build a personalised Verbio view in just a few minutes. Start with Do it your way. A great starting point for your Verbio research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If Verbio has sharpened your interest, do not stop there. The screener can surface other opportunities that fit your style before the market fully pays attention. Spot potential value candidates early by checking companies that appear on our 229 high quality undervalued stocks list before they are widely discussed. Prioritise strength and resilience by filtering for businesses in the solid balance sheet and fundamentals stocks screener (371 results) so you focus on firms with healthier financial footing. Hunt for quieter opportunities with quality traits using the screener containing 558 high quality undiscovered gems and see which names others might be overlooking. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free